I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
First-In-Human Study on Pharmacokinetics, Safety, and Toler..:
Hong Zhang
;
Lei Gao
;
Jinfeng Lou
...
https://www.frontiersin.org/articles/10.3389/fphar.2022.873588/full. , 2022
Link:
https://doi.org/10.3389/fphar.2022.873588
RT Journal T1
First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:bdc071679ee3447090eceb5b35747935&Exemplar=1&LAN=DE A1 Hong Zhang A1 Lei Gao A1 Jinfeng Lou A1 Min Wu A1 Hong Chen A1 Lizhi Yang A1 Jingrui Liu A1 Xiaoxue Zhu A1 Xiaojiao Li A1 Cuiyun Li A1 Meng Wang A1 Chengjiao Liu A1 Weibo Guo A1 Yuan Wang A1 Zhongqiang Gao A1 Lei Han A1 Daidi Wang A1 Weili Jin A1 Yanhua Ding PB Frontiers Media S.A. YR 2022 K1 clinical trial K1 pharmacokinetics K1 prodrug K1 tenofovir K1 HBV K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2022.873588/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2022.873588 DO https://doi.org/10.3389/fphar.2022.873588 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)